Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Myriad Genetics Inc (NASDAQ:MYGN)

36.82
BATS BZX Real-Time Price
As of 1:29pm ET
 +1.03 / +2.88%
Today’s Change
15.15
Today|||52-Week Range
37.30
+7.21%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Revenue and IncomeNet Revenues196.5M196.9M200.5M190.2M
 
 
 
 
 
Cost of Goods Sold31.4M31.4M29.2M29.8M
 
 
 
 
 
Depreciation And Amortization13.0M12.9M13.3M13.2M
 
 
 
 
 
 
Operating ExpensesGross Income152.1M152.6M158.0M147.2M
 
 
 
 
 
General Expenses137.6M138.0M119.2M133.0M
 
 
 
 
 
Research And Development18.6M17.6M18.8M17.8M
 
 
 
 
 
Total Operating Expenses182.0M182.3M161.7M176.0M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income14.5M14.6M38.8M14.2M
 
 
 
 
 
Extraordinary Credit0.000.002.7M73.2M
 
 
 
Extraordinary Charge-1.3M-6.9M-21.7M0.00
 
 
 
 
Interest Expense On Debt2.6M1.5M1.2M900.0K
 
 
 
 
 
Other Expenses1.2M1.5M-100.0K-300.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income12.1M8.0M18.8M86.6M
 
 
 
 
 
Income Taxes-6.2M-3.8M-6.1M-5.6M
 
 
 
 
 
Minority Interest0.000.00-200.0K-100.0K
 
 
 
Net Income5.9M4.2M12.9M81.1M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS68.2M68.1M68.2M68.6M
 
 
 
 
 
Shares To Calculate EPS Diluted68.3M68.3M68.9M70.4M
 
 
 
 
 
 
Earnings Per ShareEPS$0.09$0.06$0.19$1.15
 
 
 
 
 
EPS Diluted$0.09$0.06$0.19$1.15